이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2021. 6. 24.1 분 읽기
Premenopausal Women With Breast Cancer: Developing Drugs for Treatment; Guidance for Industry; Availability
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Premenopausal Women with Breast Cancer: Developing Drugs for Treatment." This guidance provides recommendations regarding the inclusion of premenopausal women in breast cancer clinical trials. The guidance is intended to assist stakeholders, including sponsors and institutional review boards, responsible for the development and oversight of clinical trials for breast cancer drugs. This guidance finalizes the draft guidance of the same title issued on October 8, 2020.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →